PLSE today
$50.44-$1.81 (-3.46%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minLeaning Bullish
5 minExpanding
Daily trend turns up above $58.90
Key levels
Resistance$56.51
Support$47.47
Support$43.32
Latest news & SEC filings
AnalystCanaccord Genuity keeps Buy rating on Pulse Biosciences, lifts target to $74
NewsPulse Biosciences reports six-month interim data from PRECISE-BTN study
AnalystNeedham lifts its valuation target for Pulse Biosciences to $64
All PLSE news →About Pulse Biosciences
Pulse Biosciences is a medical device company developing ablation technology based on nanosecond-duration electrical pulses, known as Nano-pulse Stimulation. Its nPulse platform delivers this energy through disposable applicators, including the Vybrance percutaneous electrode for soft tissue ablation and cardiac surgical and catheter devices for treating atrial fibrillation. The company also previously commercialized the system for dermatologic skin lesion treatment. It operates primarily in the United States and Europe, serving physicians and surgeons.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
PULSE BIOSCIENCES, INC. (PLSE)
What Is the Price Target for PLSE?
SEPT Low Target
$60.00
SEPT Mid Target
$71.50
SEPT High Target
$74.00
Analyst Consensus
$71.50
Is PLSE a Buy or Sell Right Now?
Thesis
- •Revenue growing -50.0% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PLSE.
Start Free Trial →Is PLSE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$71.50
12
Moat Score
NONE
2/9
Piotroski Score
146.0
Altman Z-Score
What Is Smart Money Doing with PLSE?
Insider Signal
NEUTRAL
5 buys / 7 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Teplitsky Liane Rae | officer | Buy | 1,001 | $50K | Sep 1, 2026 |
| Teplitsky Liane Rae | officer | Buy | 1,024 | $50K | Aug 31, 2026 |
| Teplitsky Liane Rae | officer | Buy | 1,034 | $50K | Aug 28, 2026 |
| Teplitsky Liane Rae | officer | Buy | 1,036 | $50K | Aug 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PLSE Growth Story
Revenue YoY
-50.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
-49.3%
Revenue Trend
DECLINING
Dark Pool Trades for PLSE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PLSE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:23:54 | $51.14 | 4,786 | $$245K | SELL |
| 16:22:48 | $51.10 | 4,000 | $$204K | SELL |
| 16:21:26 | $50.87 | 2,368 | $$120K | SELL |
| 16:21:20 | $51.01 | 1,200 | $$61K | SELL |
| 16:19:51 | $51.01 | 1,084 | $$55K | SELL |
5 dark pool trades shown · $$686K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PULSE BIOSCIENCES, INC. (PLSE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (7 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PLSE — frequently asked questions
What is PLSE stock price today?
PULSE BIOSCIENCES, INC. (PLSE) is at $50.44, down 3.46% (-$1.81) at the Nov 13, 2026 close.
Why is PLSE stock moving today?
Latest PLSE news — Nov 6, 2026: Canaccord Genuity keeps Buy rating on Pulse Biosciences, lifts target to $74 · Nov 6, 2026: Pulse Biosciences reports six-month interim data from PRECISE-BTN study
Why did PLSE stock move on Nov 6, 2026?
Pulse Biosciences shares fell 6.30% to close at $53.29, trading between a low of $50.31 and a high of $56.87 on volume of 425,930. The decline came despite bullish analyst actions, as Canaccord Genuity maintained its Buy rating and raised its price target to $74, while Needham reiterated its Buy rating and lifted its target to $64.
What is the PLSE price target?
The average analyst price target for PLSE is $71.50, ranging from $60 to $74, based on 6 analysts. Latest: Canaccord Genuity maintains on Nov 6, 2026.
What do analysts rate PLSE?
Analyst ratings for PLSE: 0 Buy, 9 Hold, 0 Sell — consensus Hold.
Did PLSE beat earnings?
PLSE last reported on Nov 5, 2026: EPS -$0.32 vs -$0.31 expected — a miss of 3.4%.
Does PLSE pay a dividend?
PLSE does not currently pay a dividend.
What are PLSE support and resistance levels?
Support: $47.47, $43.32, $33.87. Resistance: $56.51.
What are insiders doing with PLSE?
Insider activity: NEUTRAL, 5 buys and 7 sells in the last 90 days.
What is the latest news on PLSE?
Nov 6, 2026: Canaccord Genuity keeps Buy rating on Pulse Biosciences, lifts target to $74 · Nov 6, 2026: Pulse Biosciences reports six-month interim data from PRECISE-BTN study · Nov 6, 2026: Needham lifts its valuation target for Pulse Biosciences to $64